The striking association between hepatitis C virus (HCV) infection and
the so-called ''essential'' mixed cryoglobulinemia (MC) has led to th
e hypothesis that HCV plays a major role in the production of cryoglob
ulins. Analysis of soluble and cryoprecipitable immune complexes shows
that the hepatitis C virion is bound to IgM bearing the WA cross-idio
type (Xld), The production of WA Xld IgM seems to be the result of chr
onic stimulation by HCV of a population of WA Xld+ CD5+ B cells. It is
possible that the reactivity of WA XldIgM does not initially include
rheumatoid factor (RF) activity, which may be acquired secondarily fro
m mutational events accompanying a probably T-cell independent B cell
proliferation. Type II MC is a benign proliferation that progresses to
malignancy in a minority of patients. This is consistent with the con
cept that malignancy progression involves the accumulation of multiple
mutations of proto-oncogenes and tumor suppressor genes that are faci
litated by chronic antigenic stimulation. The recent demonstration of
HCV in hyperplastic reactive lymphoadenopathy and in the neoplastic ly
mph nodes of patients with MC strengthens the putative role played by
HCV in lymphomagenesis. A fuller understanding of the virus-related me
chanisms of lymphoproliferation in MC patients would contribute signif
icantly to the development of therapeutic strategies.